TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Moberg Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
|
196
|
0 |
Financial expenses |
263
|
68
|
234 |
Earnings before taxes |
-25,751
|
-18,457
|
-19,475 |
EBITDA |
-25,695
|
-16,690
|
-16,721 |
Total assets |
643,004
|
533,895
|
439,717 |
Current assets |
70,399
|
120,850
|
102,062 |
Current liabilities |
20,808
|
25,337
|
15,153 |
Equity capital |
618,684
|
504,724
|
423,296 |
- share capital |
28,325
|
9,295
|
4,296 |
Employees (average) |
10
|
8
![]() |
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
96.2%
|
94.5%
|
96.3% |
Turnover per employee |
0
|
24
|
0 |
Profit as a percentage of turnover | -9416.8% | ||
Return on assets (ROA) |
-4.0%
|
-3.4%
|
-4.4% |
Current ratio |
338.3%
|
477.0%
|
673.5% |
Return on equity (ROE) |
-4.2%
|
-3.7%
|
-4.6% |
Change turnover |
-210
|
196
|
-49,237 |
Change turnover % | -100% | -100% | |
Chg. No. of employees |
2
|
0
|
-3 |
Chg. No. of employees % |
25%
|
0%
|
-27% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.